Drug Class
PI3K delta and CK1 epsilon inhibitor
Type
brand
Active Ingredient
umbralisib
📋Overview
Ukoniq is a prescription medication that contains the active ingredient umbralisib. It is classified as a kinase inhibitor and is primarily associated with the treatment of certain types of blood cancers, such as marginal zone lymphoma and follicular lymphoma. Ukoniq works by targeting specific enzymes involved in the growth and survival of cancer cells. Its use is generally reserved for cases where other therapies may not have been effective.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Ukoniq
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.